India Infoline News
-
Ranbaxy Laboratories Ltd., the Indian drugmaker whose exports to the U.S. were restricted after a fraud investigation, may revive sales to its biggest market after resolving the charges that it sold adulterated medication.
-
Traders are buying the largest amount of bearish options on Hindustan Unilever Ltd. in three months to hedge against declines in a stock that surged 17 percent following a Unilever Plc offer to raise its stake.
-
Following is a table showing commercial papers reported by Companies. The data has been provided by the Fixed Income Money Market & Derivatives Association of India.
-
Indian stock-index futures rose, signaling stocks may extend the biggest weekly increase in more than four months.
-
Options traders who bet Infosys Ltd.’s sales outlook would surprise investors tripled their money today as the stock tumbled the most in a decade.
-
Claris Lifesciences Ltd. may be the next takeover target among Indian injectable-drug producers as a shortage of medicines in the U.S. prompts buyers to seek companies with approved manufacturing facilities.
-
Carlyle Group LP acquired a 9 percent stake in Mumbai-based brokerage India Infoline Ltd., the second investment by its Asian buyout fund in the nation.
-
India Infoline Ltd. , an Indian brokerage, advised Money Matters Financial Services Ltd. for a sale of shares to large investors this year and hasn’t used the securities firm for debt syndication or lending money.
-
Nirmal Jain, chairman of brokerage India Infoline Ltd., comments on the outlook for Indian stocks in an interview with Bloomberg UTV today.
-
India Infoline Ltd. climbed in Mumbai trading after the Carlyle Group LP acquired a 9 percent stake in the Mumbai-based brokerage.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page